Latest SPRO reports update at 2024-05-15: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Spero Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Spero Therapeutics logo
Spero Therapeutics SPRO
$ 1.4 -2.1%
mail-toReport an Error

Spero Therapeutics EV/EBITDA Ratio 2011-2024 | SPRO

Annual EV/EBITDA Ratio Spero Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.55 -3.11 -2.34 -2.79 1.33 - -4.39 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.33 -4.39 -2.47